US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% META $721.31 ▼-2.38%
FinancialContent

Latest News about Reunion Neuroscience Inc/

Recent news which mentions Reunion Neuroscience Inc/

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
Tickers MSSTF
Tags Benzinga Markets Next/Generation Psychedelics
From Benzinga
Former Field Trip Health, Now Reunion Neuroscience: Q1 2023 Financial Results & Corporate Reorganization
Tags Field Trip Health Markets Joseph del Moral
From Benzinga
Field Trip's Phase I Clinical Study Of Psilocybin Analog FT-104 Begins Dosing In Australia
Tags Field Trip Health Ltd Benzinga Joseph del Moral
From Benzinga
Field Trip Health To Divide Into Two Separate Public Companies
Tickers FTRP
Tags Markets Field Trip Health Field Trip Digital
From Benzinga